Literature DB >> 31841181

Circ_0091579 promotes proliferative ability and metastasis of liver cancer cells by regulating microRNA-490-3p.

W-Y Niu1, L Chen, P Zhang, H Zang, B Zhu, W-B Shao.   

Abstract

OBJECTIVE: To explore the role of Circular RNA 0091579 in the progression of liver cancer (LCa) and its molecular mechanism. PATIENTS AND METHODS: Quantitative polymerase chain reaction (qPCR) was used to detect circ_0091579 expression levels in LCa tissues and adjacent tissues, which was further verified in LCa cells and normal liver epithelial cells. After circ_0091579 was knocked down in Huh7 and HepG2 cells, cell counting kit-8 (CCK-8), plate cloning and transwell assays were performed to verify the effect of circ_0091579 on cell proliferative ability and metastasis of LCa cells. The starBase database was used to search for microRNAs that could interact with circ_0091579, and the Dual-Luciferase reporter gene was used to verify their binding relationship.
RESULTS: circ_0091579 was highly expressed in HCC and HCC cells. In vitro experiments showed that down-regulation of circ_0091579 expression could remarkably inhibit the proliferative ability and metastasis of HCC cells. Bioinformatics software predicted the binding sites between circ_0091579 and microRNA-490-3p, and dual-luciferase reporter gene assay confirmed the binding relationship between circ_0091579 and microRNA-490-3p. qPCR results showed that microRNA-490-3p was remarkably down-regulated in LCa tissues. In vitro experiments confirmed that overexpression of microRNA-490-3p inhibited the proliferative ability and metastasis of HCC cells.
CONCLUSIONS: circ_0091579 is abnormally highly expressed in LCa tissues and cells. Down-regulation of circ_0091579 can inhibit the proliferative ability and metastasis of HCC cells by regulating microRNA-490-3p, thus accelerating the progress of the tumor.

Entities:  

Year:  2019        PMID: 31841181     DOI: 10.26355/eurrev_201912_19664

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

Review 1.  Circular RNA as a Novel Biomarker and Therapeutic Target for HCC.

Authors:  Hongwu Meng; Ruowen Niu; Cheng Huang; Jun Li
Journal:  Cells       Date:  2022-06-17       Impact factor: 7.666

2.  The Hsa_circ_0091579/miR-940/TACR1 Axis Regulates the Development of Hepatocellular Carcinoma.

Authors:  Peiqiang Jiang; Wei Han; Yu Fu; Qingmin Chen
Journal:  Cancer Manag Res       Date:  2020-09-28       Impact factor: 3.989

3.  Circular RNA hsa_circ_0091579 facilitates the Warburg effect and malignancy of hepatocellular carcinoma cells via the miR-624/H3F3B axis.

Authors:  Y Chen; S Song; L Zhang; Y Zhang
Journal:  Clin Transl Oncol       Date:  2021-05-01       Impact factor: 3.405

4.  Circ_0091579 Serves as a Tumor-Promoting Factor in Hepatocellular Carcinoma Through miR-1225-5p/PLCB1 Axis.

Authors:  Di Zhang; Yu Zhang; Xiwu Zhang; Hongjun Zhai; Xiaoli Sun; Yiming Li
Journal:  Dig Dis Sci       Date:  2021-02-08       Impact factor: 3.199

5.  Circ_0001175 Promotes Hepatocellular Carcinoma Cell Proliferation and Metastasis by Regulating miR-130a-5p.

Authors:  Liheng Li; Ke He; Siliang Chen; Wenjiang Wei; Zuofu Tian; Yinghong Tang; Chengjiang Xiao; Guoan Xiang
Journal:  Onco Targets Ther       Date:  2020-12-31       Impact factor: 4.147

Review 6.  The function and regulation network mechanism of circRNA in liver diseases.

Authors:  Panpan Wang; Yunhuan Zhang; Lugang Deng; Zhi Qu; Peisen Guo; Limin Liu; Zengli Yu; Peixi Wang; Nan Liu
Journal:  Cancer Cell Int       Date:  2022-03-31       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.